Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02411006 · ClinicalTrials.gov registry record · NA

Effect of Reminders on Adherence

A NA study of Hypertension and Diabetes, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
47,088
Enrollment target
1
Study location

NCT02411006: Completed NA study of Hypertension and Diabetes, sponsored by University of Pennsylvania.

NCT02411006 is a NA study of Hypertension and Diabetes that has completed, run by University of Pennsylvania. The registered enrollment target is 47,088 participants, above the 3,407-participant average among 470 other Hypertension trials with a reported enrollment target (1282% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02411006, a NA study of Hypertension and Diabetes, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
47,088 participants
Enrollment target
1
Study location

Study Summary

The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence.

Primary Outcome

frequency of refilling medication

Conditions Studied

Hypertension Diabetes

Interventions

  • BEHAVIORAL Prediction mailing
  • BEHAVIORAL Commitment mailing
  • BEHAVIORAL Reminder
  • BEHAVIORAL Anonymity
  • BEHAVIORAL Identification

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 47,088 participants
Start Date 2014-11
Est. Completion 2015-06
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT02411006 record still lists

NCT02411006 is an interventional study that assigns participants to a tested intervention. Its 47,088 participants enrollment target places it among the larger protocols in the corpus, above the 3,407-participant average among 470 other Hypertension trials with a reported enrollment target (1282% higher).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 5 interventions - of which Prediction mailing is the first listed.

NCT02411006 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02411006 about?

NCT02411006 is a clinical study titled "Effect of Reminders on Adherence". The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence.

What is the current status of trial NCT02411006?

This trial is currently completed. It is a NA study. The enrollment target is 47,088 participants. The study started on 2014-11. Estimated completion is 2015-06.

What conditions does trial NCT02411006 study?

This clinical trial studies the following conditions: Hypertension, Diabetes.

What interventions are being tested in trial NCT02411006?

The interventions under investigation include: Prediction mailing (BEHAVIORAL), Commitment mailing (BEHAVIORAL), Reminder (BEHAVIORAL), Anonymity (BEHAVIORAL), Identification (BEHAVIORAL).

Who is sponsoring clinical trial NCT02411006?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02411006 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02411006's enrollment target sits among peer trials

47,088 6th of 470 higher than 465 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03977402 · 47,500 participants

    Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

  • NCT06655974 · 48,000 participants · NA

    Predictive Modeling for Social Needs in Emergency Department Settings

  • NCT06597968 · 45,991 participants

    Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool

  • NCT06824350 · 45,450 participants · NA

    Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02411006, the US trial registry maintained by the National Library of Medicine. NCT02411006 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.